Creative Planning’s OncoSec Medical Incorporated ONCS Stock Holding History

Creative Planning’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-224	Closed	-$93K	–	2218
2018 Q1	$93K	Buy	224 +136	+155%	+$55.8K	﹤0.01%	1762
2017 Q4	$31K	Buy	+88	New	+$30.8K	﹤0.01%	1836
2017 Q1	–	Sell	-5	Closed	-$1K	–	5043
2016 Q4	$1K	Buy	+5	New	+$1.72K	﹤0.01%	4548
2016 Q3	–	Sell	-1	Closed	–	–	4824
2016 Q2	$0	Hold	1	–	–	﹤0.01%	4617
2016 Q1	$1K	Hold	1	–	–	﹤0.01%	4224
2015 Q4	$1K	Hold	1	–	–	﹤0.01%	4309
2015 Q3	$1K	Buy	+1	New	+$1.31K	﹤0.01%	4204

Other funds holding ONCS

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Creative Planning's ONCS Position: Q2 2018 in Review

Creative Planning sold out of OncoSec Medical Incorporated (ONCS) in Q2 2018, closing a stake of 224 shares — an estimated $93K sold.

Creative Planning first reported a position in ONCS in Q3 2015 and held it in 7 quarters. The position peaked at $93K in Q1 2018. 34 funds tracked by Wall St. Rank hold ONCS as of Q2 2018.

Creative Planning reported no remaining OncoSec Medical Incorporated position as of Q2 2018 after selling out during the quarter.
Creative Planning sold 224 OncoSec Medical Incorporated shares in Q2 2018, an estimated $93K.
Creative Planning first reported a position in OncoSec Medical Incorporated in Q3 2015 and held it in 7 quarters.
Creative Planning's OncoSec Medical Incorporated position peaked at $93K in Q1 2018.
34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2018.

Based on Creative Planning's 13F filing for Q2 2018, filed 20 Jul 2018.